In 2013, the American Heart Association (AHA) and the American College of Cardiology (ACC) created a “risk calculator” to estimate the 10-year risk of atherosclerotic cardiovascular disease (ASCVD) ...

New dyslipidemia guidance from the American Association of Clinical Endocrinology focuses on newer medications and patient-important outcomes.

The American Heart Association, American College of Cardiology ... as presented in the 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure, is described below. Stage A (At Risk for ...

Adding the PCSK9 inhibitor led to greater absolute reductions in CVD risk than in younger patients, with no signs of safety ...

The goal is primary prevention of atherosclerotic cardiovascular disease (ASCVD ... the Framingham Heart Study led in ...

According to the 2018 Multi-Society and American College of Cardiology/American Heart Association ... for ASCVD with ASCVD risk-enhancing factors. According to the ACC/AHA cholesterol guidelines ...

Indeed, compared with other patients with ASCVD, PAD patients may ... to hyperlipidemia and hypertension. New guidelines from the American Diabetes Association have incorporated screening ABI ...